To Give Cancer Survivors a Chance to Conceive, Scientists are Designing Artificial Ovaries

The goal is to house patients’ follicles in a specially designed tissue matrix and reinsert them after treatment.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

An artificial ovary, shown, helped mice ovulate and give birth to healthy pups.IMAGE COURTESY OF NORTHWESTERN UNIVERSITYAbout 10 percent of cancer survivors are women under 40. Once they undergo chemotherapy or radiation, they may no longer be able to have a baby. So scientists are working to create artificial ovaries that could give these cancer survivors a new option for conceiving a child.

The artificial ovary is a “house” for egg-producing follicles, just like the original ovary, Christiani Amorim, who studies animal reproduction at Université catholique de Louvain in Belgium, tells The Scientist by email. “We aim to recreate the right conditions the follicles need to survive.”

Several groups are competing and collaborating to develop the perfect artificial ovary, and so far studies show it is possible to use the synthetic organ to restore ovarian function in mice. Perfecting the structure, stiffness, and capabilities of the human artificial ovary is now the focus, with teams nearing the point where they could start testing them out in women. If shown to work, this structure could have other uses too, in everything from toxicology studies to postponing childbearing to possibly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Ashley Yeager

    Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution